The Latest from Switzer

Are these stocks the buys of the century?
Switzer Report Subscriber Exclusive
Shares

Are these stocks the buys of the century?

Hedge funds and other short sellers have had a picnic dumping any stock where AI could possibly threaten the underlying business. But are we seeing…

Peter Switzer 16 Feb
Can it get any worse for CSL?
Switzer Report Subscriber Exclusive
Shares

Can it get any worse for CSL?

Are bad times behind this leading global biotechnology company founded in Australia in 1916?

Paul Rickard 16 Feb
“HOT” stock: Breville Group (BRG)
Switzer Report Subscriber Exclusive
Shares

“HOT” stock: Breville Group (BRG)

In our “HOT” stock column today, Raymond Chan, Adviser & Head of Asian Desk, explains why Morgans maintains its BUY rating for Breville Group (BRG).

Maureen Jordan 16 Feb
3 potential medical device stars
Switzer Report Subscriber Exclusive
Shares

3 potential medical device stars

Here are three promising (though not yet profitable and speculative) companies trying to emulate that success of medical device companies such as Cochlear and RedMed.

James Dunn 16 Feb
Buy, Hold, Sell…What The Brokers Say
Switzer Report Subscriber Exclusive
Buy, Sell, Hold

Buy, Hold, Sell…What The Brokers Say

For the week ending Friday, February 13, 2026, FNArena tracked 31 upgrades and 12 downgrades for ASX-listed companies from brokers monitored daily.

Rudi Filapek-Vandyck 16 Feb
This is where you remember who you are
Switzer Report Subscriber Exclusive
Switzer on Saturday

This is where you remember who you are

It was another crazy week when speculation continued about how good businesses could be attacked by AI-driven rivals.

Peter Switzer 14 Feb